CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-22 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −1,100 | 108,076 | ||
| 2025-12-22 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,194 | 107,981 | ||
| 2025-12-22 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +1,100 | $7.80 | $9K | 317,078 |
| 2025-12-22 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +2,194 | $8.46 | $19K | 319,272 |
| 2025-12-22 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +1,100 | $3.99 | $4K | 320,372 |
| 2025-12-22 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −4,394 | $17.50 | $77K | 315,978 |
| 2025-12-22 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −1,100 | 112,150 | ||
| 2025-12-22 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,194 | 106,982 | ||
| 2025-12-22 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −1,100 | 109,075 | ||
| 2025-12-15 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +37,750 | $7.80 | $294K | 370,596 |
| 2025-12-15 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +19,423 | $8.46 | $164K | 390,019 |
| 2025-12-15 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +39,849 | $3.99 | $159K | 429,868 |
| 2025-12-15 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −113,890 | $15.57 | $1.8M | 315,978 |
| 2025-12-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −37,750 | 113,250 | ||
| 2025-12-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −19,423 | 109,176 | ||
| 2025-12-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −39,849 | 110,175 | ||
| 2025-12-10 | HERSHBERG ROBERT Director | Sale | −22,968 | $16.00 | $367K | 46,722 |
| 2025-12-04 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise 10b5-1 | +4,290 | $12.14 | $52K | 301,081 |
| 2025-12-04 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise 10b5-1 | +4,157 | $8.46 | $35K | 305,238 |
| 2025-12-04 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise 10b5-1 | +4,157 | $3.99 | $17K | 309,395 |
Page 23 of 120 · 2,386 trades